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Summary  In  this  report,  we  describe  the  ﬁrst  chronic  case  of  Q  fever  endocarditis
in  a  72-year-old  woman  in  Iran.  The  patient  developed  radiation-associated  heart
disease  status  post  (s/p)  coronary  artery  bypass  surgery,  mitral  and  aortic  valve
replacements,  and  tricuspid  valve  repair.  Endocarditis  was  also  suspected  due  to  a
history  of  heart  valve  surgery.  Blood  cultures  were  negative,  but  a  diagnosis  of  QIran
fever  endocarditis  was  conﬁrmed  based  on  serologic  titers  (IgG  phase  I  1:32,768).
The  patient  was  treated  with  doxycycline  and  hydroxychloroquine.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.
t
hCase reportThe  patient  was  a  single  72-year-old  Iranian  woman
had  migrated  to  the  United  States  at  the  age  of  24
years. She  had  worked  as  a  nurse  in  Chicago  and
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1876-0341/© 2015 King Saud Bin Abdulaziz University for Health Scieraveled  to  Iran  for  2—3  months  each  year  to  visit
er family.  The  patient  returned  to  Iran  in  2009  liv-
ng in  a  suburb  in  Tehran.  She  recently  had  contact
ith wild  pigeons,  and  there  was  a farm  located  in
er neighborhood.  Pastures  for  grazing  sheep  and
oats were  located  approximately  2  km  from  the
atient’s  house,  and  animals  have  been  observed
o travel  near  her  home.
The  patient  had  a history  of  hypertension,  breast
ancer,  mastectomy,  radiotherapy  with  cobalt  (Co)
or 5  weeks  (1970),  atrial  ﬁbrillation  (1996),
nces. Published by Elsevier Limited. All rights reserved.
Q  fever  endocarditis  in  Iran  
Table  1  Biochemical  and  hematological  laboratory
test  results  on  the  ﬁrst  day  of  admission.
WBC  5700
Serum  cr  0.74
Pleural  ﬂuid  protein  4.3
Serum  protein  7.2
Pleural  ﬂuid  LDH  121
Serum  LDH  227
Pleural  ﬂuid  WBC 1485  (84%  lymph)
Pleural  ﬂuid  cytology Negative
Blood  cultures  6× Negative
Urine  culture 10,000  ≤  Gram  negative  rod
Pleural  ﬂuid  culture  Negative
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1:32,768,  respectively.  According  to  these  results,PPD  Positive
ypothyroidism  (2005),  bilateral  knee  arthroscopy,
holecystectomy,  aortic  valve  replacement  (AVR),
itral valve  replacement  (MVR),  aortic  arch  bypass
raft surgery  (2007),  tricuspid  valve  repair  (2007),
steoporosis,  atrial  ﬁbrillation,  proximal  aortic  cal-
iﬁcation, severe  stenosis  of  aortic  valve,  stenosis
nd failure  of  the  mitral  valve,  and  coronary  heart
isease.  The  patient  had  been  immunized  with  the
acillus Calmette-Guérin  (BCG)  vaccine  and  was  a
moker during  1978—1996  and  for  a few  months
n 2007.  The  patient  had  drug  sensitivity  to  sim-
astatin,  atorvastatin,  heparin,  and  narcotic  drugs.
n the  USA,  She  had  consumed  a  small  amount  of
lcohol per  year  and  consumed  pasteurized  dairy
roducts.
The patient  was  hospitalized  in  Iran  on  February
, 2012  due  to  fever,  chills,  cold  swelling,  ascites,
nd  clay-colored  bowel  movement.  She  had  fever
or the  ﬁrst  3  days  of  hospitalization,  after  which
er condition  improved  for  3 days;  however,  the
ever relapsed.  On  initial  examination,  the  blood
ressure,  heart  rate,  and  oxygen  (O2)  saturation  at
oom ambiance  were  103/53  mmHg,  80  beats/min,
nd 92%,  respectively.  A  pleural  tap  was  carried  out
nd she  underwent  cardiac  catheterization.  Due  to
 urinary  tract  infection,  she  was  treated  with  a
ourse of  Ciproﬂoxacin  for  10  days.  There  was  no
eukocytosis,  the  pleural  ﬂuid  was  exudative,  and
lood cultures  were  negative  (Table  1).
She traveled  to  the  United  States  10  days  after
ospital admission  in  Iran.  On  February  23,  2012,
he was  hospitalized  in  Boston  due  to  shortness
f breath  and  coughing,  followed  by  the  develop-
ent of  intermittent  fever  for  1  week.  The  fever
as accompanied  by  night  sweats  and  chills  with-
ut shivering;  there  was  no  daytime  fever.  Several
eeks prior  to  this  incident,  she  had  a  mild  nonpro-
uctive cough.  She  did  not  have  dysuria  or  urgency.
he experienced  2—3  kg  weight  loss  several  months
efore hospitalization.
Q
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According  to  a CT  scan  of  the  lungs,  pleural  effu-
ion in  the  right  lower  lobe  (scattered  opacity  with
round  glass  appearance),  centrilobular  emphy-
ema in  the  superior  lobe,  and  scattered  osteopenia
n the  thoracic  vertebrae  were  observed.  No
vidence of  endocarditis  was  present  on  echocar-
iography.
The patient  was  hospitalized  and  treated  for
ecompensated heart  failure  attributed  to  severe
ricuspid  regurgitation  as  the  primary  diagnosis,  but
he fever  and  dry  cough  persisted.  On  February  28,
 pleural  tap  was  performed  and  she  underwent
ardiac catheterization  on  March  1,  which  revealed
cclusions  of  her  vein  grafts  to  the  right  coronary
rtery (RCA)  and  left  anterior  descending  artery
LAD) and  elevated  right  atrial  pressures  attributed
o severe  tricuspid  regurgitation.  According  to  the
ransesophageal  echocardiogram,  severe  tricuspid
egurgitation  was  conﬁrmed,  and  well  situated
itral and  aortic  bioprosthetic  valves  with  no
vidence  of  valvular  vegetation  were  observed.
nfection was  considered  a precipitating  factor  for
ecompensated  heart  failure.  However,  viral  pneu-
onia was  also  a  suitable  differential  diagnosis
ccording to  the  affected  region  in  the  lung  and
he duration  of  disease.  Tuberculosis  was  unlikely
ue to  the  pattern  of  pulmonary  involvement.  Lung
nfarction  was  a possibility  according  to  the  differ-
ntial diagnosis  based  on  the  computed  tomography
can. We  isolated  the  patient,  and  a sputum  test
or tuberculosis,  diagnostic  panel  of  respiratory
iruses, and  repeated  blood  cultures  were  con-
ucted.
After  6  days  of  hospitalization,  the  patient
as temporarily  discharged  because  she  did  not
ave fever  during  the  previous  2  days.  After  dis-
harge,  the  fever  recurred  and  shortness  of  breath
ncreased.  Furthermore,  she  was  unable  to  climb
he stairs  for  more  than  a  half  set  of  stairs.  Blood
ultures were  found  to  be  negative  again.  We  were
nable  to  detect  Bartonella  henselae  immunoglob-
lin M  and  G,  Bartonella  quintana  immunoglobulin
 and  G,  brucellosis  immunoglobulin  M  and  G,
uberculosis  (T-SPOT),  or  human  immunodeﬁciency
irus (HIV)  infection  using  serologic  analyses.  At  the
econd stage,  phase  I  and  II antibodies  against  Cox-
ella burnetii  (IgM  &  IgG)  were  evaluated  by  indirect
mmunoﬂuorescent  assay  (Focus  Diagnosis,  Cypress,
A, USA)  and  antibody  titers  of  IgM  and  IgG  phase
 against  C.  burnetii  were  1:2048  and  1:32,768,
espectively. Furthermore,  antibody  titers  of  IgM
nd IgG  phase  II against  C.  burnetii  were  1:128  and fever  endocarditis  was  considered  the  ﬁnal  diag-
osis for  this  patient,  which  is  superimposed  on
adiation-associated  heart  disease.
500  F.  Yaghmaie  et  al.
Table  2  Serologic  results  for  Coxiella  burnetii  using  the  immunoﬂuorescent  antibody  (IFA)  test.
Date  IgM  I  IgM  II  IgG  I IgG  II
03/08/2012  1:2048  1:128  1:32,768  1:32,768
03/12/2012  —  —  1:32,768  1:16,384
03/16/2012  1:2048  1:256  1:32,768  1:32,768
04/06/2012  1:2048  1:256  1:32,768  1:32,768
07/03/2012  1:256  1:128  1:32,768  1:8192
01/08/2013  Negative  Negative  1:4196  1:1024
06/09/2013  Negative  Negative  1:2048  1:1024
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gThe  patient  was  asked  to  return  to  the  hospital
for further  evaluation  and  treatment  of  Q  fever.  At
this time,  her  blood  pressure,  heart  rate,  O2 satu-
ration at  room  temperature,  and  body  temperature
were 119/67  mmHg,  96  beats/min,  96%,  and  37 ◦C,
respectively.  Icterus  and  rash  were  not  observed
during the  skin  examination.  The  head,  neck,
and pharynx  physical  examination  were  normal.
Lung auscultation  indicated  decreased  pulmonary
sounds at  the  base  of  both  lungs,  and  no  mur-
mur sounds  were  present  with  cardiac  auscultation.
The physical  examination  of  abdomen  and  extrem-
ities  were  normal.  This  patient  was  diagnosed
with infective  endocarditis  using  the  modiﬁed  Duke
criteria, including  a  phase  I  IgG  antibody  titer
>1:800 for  C.  burnetii  (as  major  criteria)  and  minor
criteria such  as  predisposing  heart  condition  and
fever.  The  patient  was  treated  with  doxycycline
100 mg  twice  daily  and  hydroxychloroquine  600  mg
daily. She  underwent  a  bioprosthetic  tricuspid  valve
replacement  in  July  2012  for  progressive  tricus-
pid regurgitation  and  right  sided  heart  failure.  In
addition,  we  monitored  her  treatment  progress  and
antibodies  against  C.  burnetii  for  several  months
(since  October  2012)  in  the  United  States  and  Iran
(Table  2).
Conclusion
We  report  a  case  of  Q  fever  endocarditis  in  a patient
from Iran.  The  ﬁrst  case  of  acute  Q  fever  in  Iran
was reported  in  1952  [1],  and  since  then,  human
seropositive cases  of  Q  fever  have  been  reported
from certain  parts  of  the  country  [2,3]. No  human
cases  have  been  reported  in  Iran  since  1976  and  the
disease was  ignored  for  many  years  [4].  In  2010,
C. burnetii  antibodies  were  reported  in  febrile
patients in  the  Kerman  province  (southeast  Iran)  [5]
and  investigation  for  Q  fever  was  resumed  in  Iran.
However,  there  have  been  no  reports  of  chronic  Q
fever in  Iran  until  now.  According  to  old  and  recent
reports regarding  the  prevalence  of  Q  fever  among
t
k
u
tomestic  and  wild  animals,  Q  fever  was  endemic  in
ran [3,4,6—10].  Q  fever  cases  were  not  diagnosed
n Iran  for  >35  years  due  to  a lack  of  diagnostic
acilities and  the  relatively  low  level  of  awareness
ithin the  Iranian  health  care  system.
The  present  patient  presented  with  congestive
eart failure  and  a history  of  AVR/MVR,  tricus-
id valve  repair,  and  coronary  artery  bypass  graft.
nitially,  endocarditis  was  suspected  due  to  the
resence  of  fever,  coughing,  and  radiographic
hanges in  the  lung,  especially  the  right  lung,  and
 history  of  heart  valve  surgery.  There  was  no  sign
f vegetation  on  echocardiography,  but  the  diag-
osis of  Q  fever  was  conﬁrmed  by  serologic  titers
IgG phase  I  1:32,768)  and  the  serologic  panel  was
pplied during  the  following  months  (since  March
012 to  June  2013).
Transmission  of  Q  fever  to  humans  occurs  mainly
hrough the  exposure  of  infected  animals  and
nhalation  of  contaminated  aerosols  [11].  Older  and
mmunocompromised  individuals  are  at  a greater
isk for  developing  chronic  Q  fever.  Endocarditis
s the  most  common  manifestation  of chronic  Q
ever, which  predominantly  occurs  in  patients  with
 history  of  valve  disorders  and/or  valve  replace-
ent surgery.  Pre-existing  valvular  heart  disease
nd prosthetic  valves  are  recognized  as  risk  fac-
ors for  Q  fever  endocarditis  [12]. In  a study  on  408
atients  with  Q  fever  endocarditis,  it  was  shown
hat underlying  valvular  heart  disease  was  almost
nvariably  present,  and  38%  of  the  patients  had
rosthetic  valves  [13].
In this  case,  the  patient  had  been  living  in  the
nited  States  until  2009  and  returned  to  Tehran,
ran afterwards.  Therefore,  there  is  a  possibility
hat the  patient  had  been  infected  in  the  United
tates and  presented  with  endocarditis  after  sev-
ral years  in  Iran.  However,  the  probability  of
etting  an  infection  in  the  United  States  is  low  given
he patient’s  history  in  the  United  States  (i.e.,  not
eeping livestock  or  pet  animals  and  not  consuming
npasteurized dairy  products).  However,  the  pas-
ure used  for  grazing  domestic  animals,  which  was
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[ fever  endocarditis  in  Iran  
ocated  near  the  patient’s  home  in  Iran,  was  as  an
mportant  reservoir  of  Q  fever.  Furthermore,  the
atient’s  symptoms  appeared  after  living  in  Iran  for
 few  years.  Therefore,  it  is  more  likely  that  the
nfection  occurred  in  Iran.
Q fever  in  the  patient  was  not  diagnosed  early  in
ran, probably  due  to  a  lack  of  experience  in  clini-
al diagnosis  and  appropriate  laboratory  facilities;
owever,  the  disease  was  diagnosed  after  evalu-
tions in  the  United  States.  The  lack  of  recent
eports regarding  acute  or  chronic  forms  of  Q  fever,
specially  endocarditis  and  the  valvular  form  might
e due  to  a  lack  of  awareness  of  clinicians  and  the
ealth care  system  in  Iran.
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